Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study
乌司奴单抗、维多珠单抗和肿瘤坏死因子抑制剂在极早期发病炎症性肠病中的真实世界疗效:一项多中心队列研究
期刊:Journal of Gastroenterology
影响因子:5.5
doi:10.1007/s00535-025-02334-9
Nambu, Ryusuke; Iwama, Itaru; Takeuchi, Ichiro; Hagiwara, Shin-Ichiro; Etani, Yuri; Kaji, Emiri; Yoden, Atsushi; Kakuta, Fumihiko; Hoshi, Yusuke; Tsumura, Naoya; Mizuochi, Tatsuki; Kumagai, Hideki; Yokoyama, Koji; Nishizawa, Takuya; Usami, Masaaki; Takaki, Yugo; Ebana, Ryo; Kurasawa, Shingo; Fujikawa, Hiroki; Ishige, Takashi; Kudo, Takahiro; Yoshida, M Masashi; Shimizu, Hirotaka; Arai, Katsuhiro